BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 222530)

  • 1. [Use of cyproheptadine in the treatment of Cushing's disease].
    Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
    Clin Ter; 1979 Feb; 88(4):345-54. PubMed ID: 222530
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on drug therapy of Cushing's syndrome].
    Winkelmann W; Fricke U; Hackenberg K; Heesen D; Hoff HG; Hummerich W; Liesen H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1337-40. PubMed ID: 347777
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyproheptadine in the control of Cushing's disease.
    Hsu TH; Gann DS; Tsan KW; Russell RP
    Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN; Valueva GV; Luchitsky EV
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with cyproheptadine of a recurrent case of Cushing's disease].
    González LR; Gándara JR
    Bol Asoc Med P R; 1976 Oct; 68(10):264-6. PubMed ID: 791301
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of cushing's disease with cypropheptadine (author's transl)].
    Michelsen H; Contreras P; Bradford I; Rojas A
    Rev Med Chil; 1977 Jun; 105(6):380-3. PubMed ID: 331429
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B; Gaggini M; Secchi F; Faglia G
    Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
    [No Abstract]   [Full Text] [Related]  

  • 9. More on cyproheptadine in Cushing's disease.
    N Engl J Med; 1977 Mar; 296(10):576-7. PubMed ID: 189191
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
    Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
    Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan].
    Slavnov VN; Valueva GV; Luchitskiĭ EV
    Ter Arkh; 1984; 56(9):119-22. PubMed ID: 6096979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug treatment of Cushing's syndrome with cyproheptadine].
    Seyer-Hansen K; Weeke J; Møller J
    Ugeskr Laeger; 1979 Sep; 141(37):2518-20. PubMed ID: 483437
    [No Abstract]   [Full Text] [Related]  

  • 13. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
    Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
    Tucci JR; Nowakowski KJ; Jackson IM
    J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potential use of the antiserotonin preparation cyproheptadine (peritol) in Itsenko-Cushing disease].
    Valueva GV; Luchitskiĭ EV; Iakovlev AA
    Farmakol Toksikol; 1983; 46(2):50-3. PubMed ID: 6852218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of aminoglutethimide in the treatment of Cushing's syndrome].
    Jacobelli A; Borgia MC; Borgia C; Sellini M
    Minerva Med; 1974 Jan; 65(3):156-62. PubMed ID: 4370585
    [No Abstract]   [Full Text] [Related]  

  • 17. The relationship between cortisol and ACTH in patients with Cushing's disease following neurosurgery or pharmacotherapy.
    Kasperlik-Załuska A; Migdalska B; Jeske W; Wiśniewska-Woźniak T; Sek S
    Endokrynol Pol; 1989; 40(2):63-7. PubMed ID: 2560712
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy.
    Whitehead HM; Beacom R; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):193-201. PubMed ID: 2161298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five cases of cyclical Cushing's syndrome.
    Atkinson AB; Kennedy AL; Carson DJ; Hadden DR; Weaver JA; Sheridan B
    Br Med J (Clin Res Ed); 1985 Nov; 291(6507):1453-7. PubMed ID: 2998540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: New drug treatment for Cushing's disease.
    Lancet; 1975 Dec; 2(7945):1135-6. PubMed ID: 53612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.